DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Firms / Windham Venture Partners
Windham Venture Partners
Institutional venture firmNew York, NYwindhamvp.comSEC venture capital fund adviserfundraising evidence
We focus on advances in medical technology and digital health to change the face of healthcare.
venture manager, reported GAV $109M across 7 vehicles
Importance
38
elevated
Active deployment
90
high
Emerging
0
low
Completeness
69
high
Freshness
100
high
Research priority
28
moderate
Identity and regulatory footprint
- Headquarters
- New York, NYadviserinfo.sec.gov
- Office address
- 500 FIFTH AVENUE, SUITE 3600, New York, NY, 10110adviserinfo.sec.gov
- Business phone
- 212-235-1091adviserinfo.sec.gov
- Website
- http://www.windhamvp.com/
- SEC adviser type
- exempt reporting adviseradviserinfo.sec.gov
- SEC exemption claimed
- venture capital fund adviseradviserinfo.sec.govItem 2.B(1): advises solely venture capital funds
- Latest Form ADV
- Jul 17, 2025
- Private funds reported
- 6 (6 venture capital funds)adviserinfo.sec.gov
- Private fund gross assets
- $94.1Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
- Owners on Schedule A
- Ffpgp, LLC (Member), E
- business email
- info@windhamcap.comwindhamcap.compublished by the subject
- business phone
- 212-235-1091adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
37 observed deals
Stated (the firm’s website)
- Sectors
- healthcare
- Stages
- not stated or not yet read
- Geography
- not stated
- Check size
- not stated; DFX does not estimate checks from round sizes
Observed (from deals on record)
Stage at participation: no observed deals yet
Stage at first entry: no observed deals yet
Sectors
unknown 92%Other Health Care 5%Biotechnology 3%
lead rate n/afollow-on rate n/anew logos, 12 months 37
Funds and vehicles
7 reported, 2 no longer reported
| Vehicle | Type | Vintage | Lifecycle | Reported GAV | Owners | Form D sold | Latest Form D |
|---|---|---|---|---|---|---|---|
| Windham Life Sciences Partners IV, L.P. | Fund | 2023 form d first sale | Fundraising | unknown | unknown | $30.8M of $150M | Nov 13, 2025 |
| Windham Life Sciences Partners II Annex Fund, L.P. | Continuation vehicle | 2022 adv first reported | Active deployment | $7.5M Mar 29, 2024 | 36 | unknown | unknown |
| Windham Life Sciences Partners III, L.P. | Fund | 2020 adv first reported | Mature | $55.6M Mar 29, 2024 | 44 | unknown | unknown |
| Wlsp Coinvestment, LLC | SPV or co-invest vehicle | 2020 adv first reported | Mature | $7.6M Mar 29, 2024 | 19 | unknown | unknown |
| Windham Life Sciences Partners II, L.P. | Fund | unknown | Unknown | $27.8M Mar 29, 2024 | 48 | unknown | unknown |
| Windham Life Sciences Partners, L.P. | Fund | unknown | Unknown | $8.5M Mar 29, 2024 | 36 | unknown | unknown |
| Windham-Crv Investment I, LLC | Fund | unknown | Unknown | $2.3M Mar 29, 2024 | 33 | unknown | unknown |
| Windham-Gs Investment, LLC | Fund | 2020 adv first reported | Wound down | $2.0M Mar 31, 2021 | 34 | unknown | unknown |
| Windham-Mc Investment I, LLC | Fund | unknown | Wound down | $3.9M Mar 30, 2020 | 43 | unknown | unknown |
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
17 current, 0 departed
Ruth Segall
AssociateAssociate
Allan Bufferd
Board or advisoryAdvisor
Bill Crouse
Board or advisoryAdvisor
Deneen Vojta
Board or advisorySenior Advisor
Jeffrey Sachs
Board or advisoryAdvisor
Sara Vaezy
Board or advisoryAdvisor
Sterling Snead
Board or advisoryAdvisor
Joe Proto
Founder or executiveCo-Founder
Roger Fine
Founder or executiveChairman and Co-Founder
Adam Fine
General partnerGeneral Partner & CEO
Laura Sage
Investor relationsDirector, Marketing & Investor Relations
Adam E Fine
Managing partnerManaging Member · since Mar 1, 2017
David Kereiakes
Managing partnerManaging Partner
Jason Helgerson
Operating partnerOperating Partner
Joseph I Proto
PartnerMember · since Jan 1, 2012
Kaylin Collins
Platform and operationsOperations Associate
Lorne Taichman
PrincipalDirector, Science & Technology
Investments on record
37 edges, 37 companies, 0 partner-attributed
“This investor” is the amount disclosed for this investor alone; it is unknown unless a source said it. The round size is the whole round.
Co-investors
16 relationships from shared deals, counted for the whole firm
Asset Management Ventures, LLC 2 shared · recurringPortfolia Venture Management, LLC 2 shared · recurringPrimer Management, LLC 1 shared · one timeVivo Capital, LLC 1 shared · one timeUnion Square Ventures 1 shared · one timeMitsui & Co. Global Investment, Inc. 1 shared · one timeInitiate Venture Partners Fund I, L.P. 1 shared · one timeBraemar Energy Ventures 1 shared · one timeAccelmed Partners II Management, LLC 1 shared · one timeRiverwalk Capital 1 shared · one timeExcel Venture Management 1 shared · one timeLightstone Ventures 1 shared · one timeNEA: New Enterprise Associates 1 shared · one timeAdjuvant Capital, LP 1 shared · one timeMenlo Ventures 1 shared · one timePruven Management Company, LLC 1 shared · one time
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
46 dated events
- Sep 16, 2026Nuvaira, Inc. no longer listed on Windham Venture Partners's portfolio pageRemoved from portfolio pagePortfolioInferenceNuvaira, Inc.Venture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026Earlens Corp no longer listed on Windham Venture Partners's portfolio pageRemoved from portfolio pagePortfolioInferenceEarlens CorpVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026Willow no longer listed on Windham Venture Partners's portfolio pageRemoved from portfolio pagePortfolioInferenceWillowVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026WellDoc no longer listed on Windham Venture Partners's portfolio pageRemoved from portfolio pagePortfolioInferenceWellDocVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026Vytronus no longer listed on Windham Venture Partners's portfolio pageRemoved from portfolio pagePortfolioInferenceVytronusVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026Vergentbio no longer listed on Windham Venture Partners's portfolio pageRemoved from portfolio pagePortfolioInferenceVergentbioVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026Valerahealth no longer listed on Windham Venture Partners's portfolio pageRemoved from portfolio pagePortfolioInferenceValerahealthVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026Upwardhealth no longer listed on Windham Venture Partners's portfolio pageRemoved from portfolio pagePortfolioInferenceUpwardhealthVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026Tailormed no longer listed on Windham Venture Partners's portfolio pageRemoved from portfolio pagePortfolioInferenceTailormedVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026SubjectWell no longer listed on Windham Venture Partners's portfolio pageRemoved from portfolio pagePortfolioInferenceSubjectWellVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026Scienceexchange no longer listed on Windham Venture Partners's portfolio pageRemoved from portfolio pagePortfolioInferenceScienceexchangeVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026Revelleaesthetics no longer listed on Windham Venture Partners's portfolio pageRemoved from portfolio pagePortfolioInferenceRevelleaestheticsVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026Personalgenome no longer listed on Windham Venture Partners's portfolio pageRemoved from portfolio pagePortfolioInferencePersonalgenomeVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026Neotract no longer listed on Windham Venture Partners's portfolio pageRemoved from portfolio pagePortfolioInferenceNeotractVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026Neuspera no longer listed on Windham Venture Partners's portfolio pageRemoved from portfolio pagePortfolioInferenceNeusperaVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026Nebula no longer listed on Windham Venture Partners's portfolio pageRemoved from portfolio pagePortfolioInferenceNebulaVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026MC10 no longer listed on Windham Venture Partners's portfolio pageRemoved from portfolio pagePortfolioInferenceMC10Venture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026Locemia no longer listed on Windham Venture Partners's portfolio pageRemoved from portfolio pagePortfolioInferenceLocemiaVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026Stryker no longer listed on Windham Venture Partners's portfolio pageRemoved from portfolio pagePortfolioInferenceStrykerVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026Glysens no longer listed on Windham Venture Partners's portfolio pageRemoved from portfolio pagePortfolioInferenceGlysensVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026Dotscorp no longer listed on Windham Venture Partners's portfolio pageRemoved from portfolio pagePortfolioInferenceDotscorpVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026INITIATE Ventures no longer listed on Windham Venture Partners's portfolio pageRemoved from portfolio pagePortfolioInferenceINITIATE VenturesVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026Cureatr no longer listed on Windham Venture Partners's portfolio pageRemoved from portfolio pagePortfolioInferenceCureatrVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026Coravin no longer listed on Windham Venture Partners's portfolio pageRemoved from portfolio pagePortfolioInferenceCoravinVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026Controlrad no longer listed on Windham Venture Partners's portfolio pageRemoved from portfolio pagePortfolioInferenceControlradVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026Clevercarehealthplan no longer listed on Windham Venture Partners's portfolio pageRemoved from portfolio pagePortfolioInferenceClevercarehealthplanVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026Alcon no longer listed on Windham Venture Partners's portfolio pageRemoved from portfolio pagePortfolioInferenceAlconVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026ChromaCode, Inc. no longer listed on Windham Venture Partners's portfolio pageRemoved from portfolio pagePortfolioInferenceChromaCode, Inc.Venture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026Cartiva no longer listed on Windham Venture Partners's portfolio pageRemoved from portfolio pagePortfolioInferenceCartivaVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026Blueprinthealth no longer listed on Windham Venture Partners's portfolio pageRemoved from portfolio pagePortfolioInferenceBlueprinthealthVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026Andros no longer listed on Windham Venture Partners's portfolio pageRemoved from portfolio pagePortfolioInferenceAndrosVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026Altoneuroscience no longer listed on Windham Venture Partners's portfolio pageRemoved from portfolio pagePortfolioInferenceAltoneuroscienceVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026Painteq no longer listed on Windham Venture Partners's portfolio pageRemoved from portfolio pagePortfolioInferencePainteqVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026Aytubio no longer listed on Windham Venture Partners's portfolio pageRemoved from portfolio pagePortfolioInferenceAytubioVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026Novocure no longer listed on Windham Venture Partners's portfolio pageRemoved from portfolio pagePortfolioInferenceNovocureVenture organization websites (about, team, portfolio, thesis, news pages)
- Jul 13, 2022Windham Life Sciences Partners II Annex Fund, L.P. first reported on Form ADV by Windham Venture Partners (Venture Capital Fund), GAV $12,357,343Fund first reported on Form ADVFundsFactWindham Life Sciences Partners II Annex Fund, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Jul 13, 2022Windham-Gs Investment, LLC no longer reported on Form ADV by Windham Venture PartnersFund no longer reportedFundsInferenceWindham-Gs Investment, LLCSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 31, 2021Windham-Mc Investment I, LLC no longer reported on Form ADV by Windham Venture PartnersFund no longer reportedFundsInferenceWindham-Mc Investment I, LLCSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 30, 2020Windham-Gs Investment, LLC first reported on Form ADV by Windham Venture Partners (Venture Capital Fund), GAV $2,005,529Fund first reported on Form ADVFundsFactWindham-Gs Investment, LLCSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 30, 2020Wlsp Coinvestment, LLC first reported on Form ADV by Windham Venture Partners (Venture Capital Fund), GAV $700,000Fund first reported on Form ADVFundsFactWlsp Coinvestment, LLCSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 30, 2020Windham Life Sciences Partners III, L.P. first reported on Form ADV by Windham Venture Partners (Venture Capital Fund), GAV $40,681,564Fund first reported on Form ADVFundsFactWindham Life Sciences Partners III, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Feb 14, 2019Windham-Crv Investment I, LLC first reported on Form ADV by Windham Venture Partners (Venture Capital Fund), GAV $6,533,014Fund first reported on Form ADVFundsFactWindham-Crv Investment I, LLCSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Feb 14, 2019Windham Life Sciences Partners II, L.P. first reported on Form ADV by Windham Venture Partners (Venture Capital Fund), GAV $40,049,515Fund first reported on Form ADVFundsFactWindham Life Sciences Partners II, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Feb 14, 2019Windham Life Sciences Partners, L.P. first reported on Form ADV by Windham Venture Partners (Venture Capital Fund), GAV $46,820,619Fund first reported on Form ADVFundsFactWindham Life Sciences Partners, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Feb 14, 2019Windham-Mc Investment I, LLC first reported on Form ADV by Windham Venture Partners (Venture Capital Fund), GAV $2,425,004Fund first reported on Form ADVFundsFactWindham-Mc Investment I, LLCSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Feb 14, 2019Windham Venture Partners first filed Form ADV (ERA, venture capital fund adviser exemption)First SEC adviser filingOrganizationFactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Classification history
- Sep 12, 2026Institutional venture firm (confirmed, 95%, cls-1)venture manager, reported GAV $109M across 7 vehicles
- Sep 12, 2026Institutional venture firm (confirmed, 95%, cls-1)venture manager, reported GAV $109M across 6 vehicles
Evidence
49 observations from 3 sources